In recent years, medical researchers have increasingly explored the therapeutic potential of cannabis, not only for symptom management but also for its possible anticancer properties. While marijuana remains a controversial topic in many political and medical circles, growing evidence suggests that specific compounds in cannabis—particularly cannabinoids such as THC and CBD—may contribute to slowing or even halting the progression of certain types of cancer.
A 2023 study published in Frontiers in Pharmacology concluded that cannabinoids exhibit antitumor effects in preclinical models of glioblastoma, an aggressive form of brain cancer. The study found that THC and CBD may reduce tumor viability by inducing apoptosis (programmed cell death) and inhibiting angiogenesis, the process by which new blood vessels form to supply tumors with nutrients.
Similarly, research from the Journal of Breast Cancer Research and Treatment has shown that cannabidiol (CBD), a non-psychoactive cannabinoid, may inhibit the proliferation of breast cancer cells while sparing healthy ones. The study highlighted CBD’s ability to modulate the expression of genes involved in cancer cell invasion and metastasis.
Cannabis’ therapeutic potential is not limited to brain and breast cancers. In a 2020 review in Cancers journal, scientists summarized multiple studies indicating that cannabinoids could play a role in treating prostate, lung, and colorectal cancers. Mechanisms under investigation include cannabinoid-induced autophagy (cellular self-digestion), immune modulation, and synergistic effects when used alongside traditional chemotherapy drugs.
Despite these promising findings, medical experts caution that cannabis is not a miracle cure. “While the preclinical data is compelling, clinical trials are essential to determine safe and effective treatment protocols,” says Dr. Donald Abrams, oncologist and professor emeritus at UCSF. “Cannabis may complement existing therapies, but we need more evidence before recommending it as a primary treatment.”
As regulatory barriers begin to fall in countries like Canada, Israel, and parts of the United States, more clinical studies are underway. These trials may soon clarify how cannabis compounds can be integrated into oncology in a scientifically grounded and legally approved manner.
Until then, patients are encouraged to consult with their healthcare providers and not self-medicate without proper medical supervision. While marijuana’s potential as a cancer treatment is promising, it remains a developing area of science that warrants cautious optimism and rigorous scrutiny.
Sources:
Torres, S. et al. (2023). Cannabinoids in Glioblastoma: New Insights from Preclinical Studies. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2023.1122048
Elbaz, M. et al. (2018). Cannabidiol-induced apoptosis in human breast cancer cells. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-018-05050-2
Moreno, E. et al. (2020). Potential Use of Cannabinoids for the Treatment of Cancer. Cancers. https://doi.org/10.3390/cancers12061555
Dabbin-Dad Newsroom
Emerging Evidence Suggests Cannabis Compounds May Combat Certain Types of Cancer
If you liked this post, say thanks by sharing it
